Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Ion Channel Modulation

Background:

• Calcium channels play critical roles in neuronal function and disease.
• T-type and N-type calcium channels are distinct targets with varying physiological roles.
• Developing selective modulators is crucial for therapeutic intervention.

Purpose of the Study:

• To synthesize novel morpholin-2-one-5-carboxamide derivatives.
• To evaluate the potential of these derivatives as blockers of T-type and N-type calcium channels.
• To identify potent and selective T-type calcium channel blockers.

Main Methods:

• One-pot Ugi multicomponent reaction for synthesis.
• In vitro electrophysiological assays for channel blocking evaluation.
• Structure-activity relationship analysis.

Main Results:

• Successful synthesis of diverse morpholin-2-one-5-carboxamide derivatives.
• Compound 5i exhibited the highest potency against T-type calcium channels (IC(50)=0.45+/-0.02 microM).
• Compounds 5d, 5f, 5k, 5n, 5o, and 6m displayed significant potency and selectivity for T-type calcium channels.

Conclusions:

• The synthesized morpholin-2-one-5-carboxamide derivatives represent a novel class of T-type calcium channel blockers.
• These compounds demonstrate potent and selective activity, suggesting therapeutic potential.
• Further investigation into these scaffolds could lead to new treatments for channelopathies.